Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H501-13. doi: 10.1152/ajpheart.00641.2012. Epub 2012 Dec 15.
During the last decade, several G protein-coupled receptors activated by endogenous metabolites have been described. These receptors respond to fatty acids, mono- and disaccharides, amino acids, or various intermediates and products of metabolism, including ketone bodies, lactate, succinate, or bile acids. Receptors of endogenous metabolites are expressed in taste cells, the gastrointestinal tract, adipose tissue, endocrine glands, immune cells, or the kidney and are therefore in a position to sense food intake in the gastrointestinal tract or to link metabolite levels to the appropriate responses of metabolic organs. Some of the receptors appear to provide a link between metabolic and neuronal or immune functions. Given that many of these metabolic processes are dysregulated under pathological conditions, including diabetes, dyslipidemia, and obesity, receptors of endogenous metabolites have also been recognized as potential drug targets to prevent and/or treat metabolic and cardiovascular diseases. This review describes G protein-coupled receptors activated by endogenous metabolites and summarizes their physiological, pathophysiological, and potential pharmacological roles.
在过去的十年中,已经描述了几种由内源性代谢物激活的 G 蛋白偶联受体。这些受体对脂肪酸、单糖和二糖、氨基酸或代谢的各种中间产物和产物,包括酮体、乳酸盐、琥珀酸盐或胆汁酸作出反应。内源性代谢物的受体存在于味觉细胞、胃肠道、脂肪组织、内分泌腺、免疫细胞或肾脏中,因此能够感知胃肠道中的食物摄入或将代谢物水平与代谢器官的适当反应联系起来。一些受体似乎在代谢和神经元或免疫功能之间提供了联系。鉴于许多这些代谢过程在病理条件下失调,包括糖尿病、血脂异常和肥胖症,内源性代谢物的受体也被认为是预防和/或治疗代谢和心血管疾病的潜在药物靶点。这篇综述描述了由内源性代谢物激活的 G 蛋白偶联受体,并总结了它们的生理、病理生理和潜在的药理学作用。